Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma. Elumalai P, Ezhilarasan D. Oral Oncol 2022;134:106100.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Elumalai P, Ezhilarasan D. Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma. Oral Oncol 2022;134:106100.
PMID: 36063701